Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer

NCT03700580 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Foot
Neuropathy, Diabetic
Foot Ulcer

Interventions

DRUG: Hydrogel treatment
DRUG: P1G10

Sponsor

Carlos E Salas